Advancements in the classification of lung adenocarcinoma have resulted in significant
changes in pathological reporting. The eighth edition of the tumour–node–metastasis (TNM) …

Cancer stem cells aggregate to form clusters, which have enhanced stem‐like properties
and metastasis potential. However, the molecular mechanisms underlying the formation of …

This study aimed to develop a deep learning (DL) model for predicting the recurrence risk of
lung adenocarcinoma (LUAD) based on its histopathological features. Clinicopathological …

Objectives The grading system proposed by the International Association for the Study of
Lung Cancer is based on a combination of predominant histologic subtypes and the …

Background Despite promising overall survival of stage I lung adenocarcinoma (LUAD)
patients, 10-25% of them still went through recurrence after surgery.[1] While it is still …

A novel histologic grading system for invasive lung adenocarcinomas (LUAD) has been
newly proposed and adopted by the World Health Organization (WHO) classification. We …

Rationale and Objectives Extraction of intratumoral and peritumoral radiomics features
combined with clinical factors to establish nomograms to predict high-grade patterns …

The Wnt/β-catenin pathway is known to be frequently dysregulated in various human
malignancies. Alterations in the genes encoding the components of Wnt/β-catenin pathway …

Background The clinicopathologic and therapeutic significance of SMARCA4 mutation in
non-small cell lung carcinoma (NSCLC) remains unclear. Methods We retrieved 575 …

Purpose We investigated the clinical impact of genomic and pathway alterations in stage I
epidermal growth factor receptor (EGFR)–mutant lung adenocarcinomas, which have a high …